Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SAFE PRO GROUP INC. (SPAI)

  • Business News
  • April 27, 2026, 12:01 UTC
  • 0
  • 1 comments

Safe Pro to Demonstrate AI-Powered Mission Planning at U.S. Army Fort Leonard Wood Maneuver Support Center of Excellence Event

Market reaction Comment Full text

IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

  • Business News
  • April 27, 2026, 12:01 UTC
  • 0
  • 1 comments

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Market reaction Comment Full text

ARDELYX, INC. (ARDX)

  • Business News
  • April 27, 2026, 12:01 UTC
  • 0
  • 1 comments

Ardelyx Announces Abstract Accepted for Poster Presentation at the NKF’s Spring Clinical Meetings

Market reaction Comment Full text

SIERRA BANCORP (BSRR)

  • Business News
  • April 27, 2026, 12:01 UTC
  • 0
  • 1 comments

Sierra Bancorp Reports First Quarter 2026 Results

Market reaction Comment Full text

BioVie Inc. (BIVI)

  • Business News
  • April 27, 2026, 12:00 UTC
  • 0
  • 1 comments

BioVie Inc. - BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinsons Disease ahead of Topline Data in 2Q26, on May 7, 2026

Market reaction Comment Full text

Thermo Fisher Scientific Inc (TMO)

  • Business News
  • April 27, 2026, 12:00 UTC
  • 0
  • 1 comments

Thermo Fisher Scientific - Thermo Fisher Scientific Signs Agreement to Sell its Microbiology Business to Astorg

Market reaction Comment Full text

Cerus Corporation (CERS)

  • Business News
  • April 27, 2026, 12:00 UTC
  • 0
  • 1 comments

Cerus Corporation - Cerus Corporation Announces New, Four-Year Supply Agreement with French Blood Establishment for INTERCEPT Blood System

Market reaction Comment Full text

Nuvation Bio Inc. (NUVB)

  • Business News
  • April 27, 2026, 12:00 UTC
  • 0
  • 1 comments

Nuvation Bio Inc. - Nuvation Bio Announces National Comprehensive Cancer Network® Adds Taletrectinib(IBTROZI®) as Recommended Option to Clinical Practice Guidelines in Oncology for Central Nervous System Cancers

Market reaction Comment Full text

Mirum Pharmaceuticals Inc (MIRM)

  • Business News
  • April 27, 2026, 12:00 UTC
  • 0
  • 1 comments

Mirum Pharma - Mirum Pharmaceuticals Announces Primary Endpoint Met in Phase 2b Portion of the AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta Virus

Market reaction Comment Full text

Allarity Therapeutics Inc. (ALLR)

  • Business News
  • April 27, 2026, 12:00 UTC
  • 0
  • 1 comments

Allarity Therapeutics Announces that the Stenoparib DRP® Test Has Received a Notice of Allowance from the US Patent and Trademark Office

Market reaction Comment Full text
  • Previous
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Search

News categories

  • Technical Exchange News(12074)
  • Event(5328)
  • SEC News(250961)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(150302)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin